Cargando…
Generation of therapeutic protein variants with the human serum albumin binding capacity via site-specific fatty acid conjugation
Extension of the serum half-life is an important issue in developing new therapeutic proteins and expanding applications of existing therapeutic proteins. Conjugation of fatty acid, a natural human serum albumin ligand, to a therapeutic protein/peptide was developed as a technique to extend the seru...
Autores principales: | Cho, Jinhwan, Lim, Sung In, Yang, Byung Seop, Hahn, Young S., Kwon, Inchan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740134/ https://www.ncbi.nlm.nih.gov/pubmed/29269881 http://dx.doi.org/10.1038/s41598-017-18029-y |
Ejemplares similares
-
Recombinant Peptide Production Platform Coupled with Site-Specific Albumin Conjugation Enables a Convenient Production of Long-Acting Therapeutic Peptide
por: Bak, Mijeong, et al.
Publicado: (2020) -
The Minimal Effect of Linker Length for Fatty Acid Conjugation to a Small Protein on the Serum Half-Life Extension
por: Cho, Jinhwan, et al.
Publicado: (2020) -
Thermostable and Long-Circulating Albumin-Conjugated Arthrobacter globiformis Urate Oxidase
por: Yang, Byungseop, et al.
Publicado: (2021) -
Chemical Modification of Cysteine with 3-Arylpropriolonitrile Improves the In Vivo Stability of Albumin-Conjugated Urate Oxidase Therapeutic Protein
por: Yang, Byungseop, et al.
Publicado: (2021) -
Effect of C-terminus Conjugation via Different Conjugation Chemistries on In Vivo Activity of Albumin-Conjugated Recombinant GLP-1
por: Park, Junyong, et al.
Publicado: (2021)